These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials. Sussman N; Ginsberg DL; Bikoff J J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839 [TBL] [Abstract][Full Text] [Related]
8. Serotonin syndrome from addition of low-dose trazodone to nefazodone. Margolese HC; Chouinard G Am J Psychiatry; 2000 Jun; 157(6):1022. PubMed ID: 10831493 [No Abstract] [Full Text] [Related]
9. Apparent interaction between nefazodone and cyclosporine. Helms-Smith KM; Curtis SL; Hatton RC Ann Intern Med; 1996 Sep; 125(5):424. PubMed ID: 8702104 [No Abstract] [Full Text] [Related]
10. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine. Owen JR; Nemeroff CB Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349 [TBL] [Abstract][Full Text] [Related]
11. Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications. Caccia S Clin Pharmacokinet; 1998 Apr; 34(4):281-302. PubMed ID: 9571301 [TBL] [Abstract][Full Text] [Related]
13. A case report of serotonin syndrome associated with combined nefazodone and fluoxetine. Smith DL; Wenegrat BG J Clin Psychiatry; 2000 Feb; 61(2):146. PubMed ID: 10732666 [No Abstract] [Full Text] [Related]
14. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Spina E; Santoro V; D'Arrigo C Clin Ther; 2008 Jul; 30(7):1206-27. PubMed ID: 18691982 [TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of the new antidepressants. Nelson JC J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670 [TBL] [Abstract][Full Text] [Related]
16. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone. Elliott AJ; Russo J; Bergam K; Claypoole K; Uldall KK; Roy-Byrne PP J Clin Psychiatry; 1999 Apr; 60(4):226-31. PubMed ID: 10221282 [TBL] [Abstract][Full Text] [Related]
17. Nefazodone withdrawal symptoms. Benazzi F Can J Psychiatry; 1998 Mar; 43(2):194-5. PubMed ID: 9533975 [No Abstract] [Full Text] [Related]
18. Parkinson's disease worsened by nefazodone. Benazzi F Int J Geriatr Psychiatry; 1997 Dec; 12(12):1195. PubMed ID: 9444544 [No Abstract] [Full Text] [Related]
19. New antidepressant drugs and the treatment of depression in the medically ill patient. Stoudemire A Psychiatr Clin North Am; 1996 Sep; 19(3):495-514. PubMed ID: 8856814 [TBL] [Abstract][Full Text] [Related]
20. Newer antidepressants and the cytochrome P450 system. Nemeroff CB; DeVane CL; Pollock BG Am J Psychiatry; 1996 Mar; 153(3):311-20. PubMed ID: 8610817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]